At the time of writing, Oscar Health Inc [OSCR] stock is trading at $14.60, down -0.07%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The OSCR shares have gain 4.96% over the last week, with a monthly amount drifted -17.42%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 7, February 2024, Oscar Health Announces Strong Results for Fourth Quarter and Full Year 2023; Introduces Full Year 2024 Outlook Including Total Company Adjusted EBITDA Profitability. In a post published today on Yahoo Finance, For the year ended December 31, 2023:.
From an analyst’s perspective:
Oscar Health Inc [NYSE: OSCR] stock has seen the most recent analyst activity on November 02, 2023, when BofA Securities upgraded its rating to a Buy and also boosted its price target to $9 from $8. Previously, BofA Securities upgraded its rating to Neutral on June 06, 2023, and elevated its price target to $8.75. On November 16, 2022, upgrade upgraded it’s rating to Overweight but maintained its price target of $4 on the stock. Morgan Stanley downgraded its rating to a Equal-Weight but stick to its price target of $5 on November 14, 2022. BofA Securities downgraded its rating to a Underperform and reduced its price target to $4.50 on June 15, 2022. BofA Securities downgraded its rating to Neutral for this stock on May 26, 2022, and downed its price target to $6. In a note dated February 14, 2022, Goldman downgraded an Sell rating on this stock and boosted its target price from $6.50 to $9.
For the past year, the stock price of Oscar Health Inc fluctuated between $3.22 and $18.55. Currently, Wall Street analysts expect the stock to reach $4.5 within the next 12 months. Oscar Health Inc [NYSE: OSCR] shares were valued at $14.60 at the most recent close of the market. An investor can expect a potential drop of -69.18% based on the average OSCR price forecast.
Analyzing the OSCR fundamentals
According to Oscar Health Inc [NYSE:OSCR], the company’s sales were 5.86B for trailing twelve months, which represents an 43.87% jump. Gross Profit Margin for this corporation currently stands at 1.0% with Operating Profit Margin at -0.04%, Pretax Profit Margin comes in at -0.05%, and Net Profit Margin reading is -0.05%. To continue investigating profitability, this company’s Return on Assets is posted at -0.08, Equity is -0.3 and Total Capital is -0.21. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.37.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 14.34 points at the first support level, and at 14.07 for the second support level. However, for the 1st resistance point, the stock is sitting at 14.81, and for the 2nd resistance point, it is at 15.01.
Oscar Health Inc [OSCR] reported earnings per share of -$0.66 for its fiscal quarter that ended on 12/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.72/share, meaning a difference of $0.06 and a surprise factor of 8.30%. By comparison, the stated earnings for the previous quarter ended on 9/29/2023 were -$0.29 per share as compared to estimates of -$0.47 per share, a difference of $0.18 representing a surprise of 38.30%.
Ratios To Look Out For
It is important to note that Oscar Health Inc [NYSE:OSCR] has a current ratio of 1.29. Considering the valuation of this stock, the price to sales ratio is 0.57, the price to book ratio is 4.17.
Transactions by insiders
Recent insider trading involved Blackley Richard Scott, Chief Financial Officer, that happened on Mar 06 ’24 when 27043.0 shares were sold. EVP, Chief Insurance Officer, Quane Alessandrea C. completed a deal on Mar 06 ’24 to sell 13233.0 shares. Meanwhile, Chief Accounting Officer Baltrus Victoria sold 33707.0 shares on Mar 04 ’24.
